Adverse Drug Reactions and Potentially Inappropriate Medication in Older Patients: Analysis of the Portuguese Pharmacovigilance Database

Adverse Drug Reactions and Potentially Inappropriate Medication in Older Patients: Analysis of the Portuguese Pharmacovigilance Database

Criteria have been developed to identify potentially inappropriate medications that can enhance adverse reactions, highly prevalent in older patient’s therapy. This study aimed to identify potentially inappropriate medications within the adverse drug reactions reported in the Portuguese pharmacovigi...

Full description

Bibliographic Details
Main Authors:	Daniel Gomes, Maria Teresa Herdeiro, Inês Ribeiro-Vaz, Pedro Lopes Ferreira, Fátima Roque
Format:	Article
Language:	English
Published:	MDPI AG 2022-04-01
Series:	Journal of Clinical Medicine
Subjects:	pharmacovigilance adverse drug reactions potentially inappropriate medication older patients
Online Access:	https://www.mdpi.com/2077-0383/11/8/2229

Similar Items

Analysis of Docetaxel Adverse Drug Reactions: A Retrospective Study Based on Iraqi Pharmacovigilance Center Database
by: Ahmed M. Hameed, et al.
Published: (2020-12-01)

Medication and the Risk of Falls: An Analysis of Adverse Drug Reactions Reported to the Portuguese Pharmacovigilance System
by: Daniela Rodrigues, et al.
Published: (2023-11-01)

Descriptions of Adverse Drug Reactions Are Less Informative in Forums Than in the French Pharmacovigilance Database but Provide More Unexpected Reactions
by: Pierre Karapetiantz, et al.
Published: (2018-05-01)

Adverse drug reaction profile in Amravati region of India: A pharmacovigilance study
by: Kishor A Bansod, et al.
Published: (2020-01-01)

Gender Differences in Adverse Drug Reactions Among Adult Patients Reported to the Iraqi Pharmacovigilance Center
by: Areej Atheer Alsaedi, et al.
Published: (2021-12-01)

Associated adverse health outcomes of polypharmacy and potentially inappropriate medications in community-dwelling older adults with diabetes
by: Lvliang Lu, et al.
Published: (2023-11-01)

Perspective of undergraduate health-care students on adverse drug reaction and pharmacovigilance
by: Ahmed Atia, et al.
Published: (2023-01-01)

Pharmacovigilance: pharmacists’ perspective on spontaneous adverse drug reaction reporting
by: Hadi MA, et al.
Published: (2017-03-01)

Pharmacovigilance of Severe Cutaneous Adverse Drug Reactions
by: Kriteeka Saini, et al.
Published: (2022-01-01)

Adverse drug reaction reporting for more than a decade: The need for pharmacovigilance policy implementation in Turkey
by: Zakir Khan, M.Phil, et al.
Published: (2022-04-01)

Drug-induced fall risk in older patients: A pharmacovigilance study of FDA adverse event reporting system database
by: Shuang Zhou, et al.
Published: (2022-11-01)

A Sex- and Gender-Based Analysis of Adverse Drug Reactions: A Scoping Review of Pharmacovigilance Databases
by: Andreea C. Brabete, et al.
Published: (2022-02-01)

Adverse Drug Reactions with Drugs Used in Multiple Sclerosis: An Analysis from the Italian Pharmacovigilance Database
by: Maria Antonietta Barbieri, et al.
Published: (2022-02-01)

Pharmacovigilance study of spontaneous adverse drug reaction in a tertiary care centre
by: Wazid Ali, et al.
Published: (2022-01-01)

Pharmacovigilance and incidence of adverse drug reactions in hospitalized pediatric patients: a mini systematic review
by: Zakir Khan, et al.
Published: (2020-08-01)

Potentially Inappropriate Prescribing and Potential Prescribing Omissions and Their Association with Adverse Drug Reaction-Related Hospital Admissions
by: Ross Brannigan, et al.
Published: (2024-01-01)

Signal Detection of Adverse Drug Reactions of Cephalosporins Using Data from a National Pharmacovigilance Database
by: Jung-Yoon Choi, et al.
Published: (2021-05-01)

Severe cutaneous adverse reactions to drugs: A real-world pharmacovigilance study using the FDA Adverse Event Reporting System database
by: Dongxuan Li, et al.
Published: (2023-04-01)

Investigation of the characteristics of medication errors and adverse drug reactions using pharmacovigilance data in China
by: Xiaofang Tan, et al.
Published: (2020-10-01)

Adverse drug reactions of macrolide therapy: analysis of spontaneous reports according to the Pharmacovigilance system
by: Skryabina A.A., et al.
Published: (2023-03-01)

Knowledge, attitude and practices of pharmacovigilance and adverse drug reaction reporting among pharmacists working in secondary and tertiary governmental hospitals in Kuwait
by: Fatemah M. Alsaleh, et al.
Published: (2017-09-01)

Adverse events with risankizumab in the real world: postmarketing pharmacovigilance assessment of the FDA adverse event reporting system
by: Yamin Shu, et al.
Published: (2023-05-01)

The role of a pharmacist in pharmacovigilance system
by: Lučić Marija M., et al.
Published: (2018-01-01)

Analysis of adverse drug reactions reported to national pharmacovigilance center of Bhutan
by: Pelden Chejor, et al.
Published: (2021-06-01)

Pharmacovigilance of cutaneous adverse drug reactions among patients attending dermatology department at a Tertiary Care Hospital
by: Shweta Sharma, et al.
Published: (2019-01-01)

A 5 year retrospective analysis of pharmacovigilance study, completeness and quality of suspected adverse drug reaction forms at adverse drug reaction monitoring center Port Blair.
by: Priyanka Hotha, et al.
Published: (2021-12-01)

A real-world pharmacovigilance analysis of FDA adverse event reporting system database for upadacitinib
by: Yan Wu, et al.
Published: (2023-08-01)

The current view of potentially inappropriate medications (PIMs) among older adults in Saudi Arabia: a systematic review
by: Fawaz M. Alotaibi
Published: (2023-12-01)

Pharmacovigilance and Adverse Drug Reaction Reporting among the General Public in Lithuania: A Cross-Sectional Study
by: Agne Valinciute, et al.
Published: (2023-04-01)

Workshop on Adverse Drug Reaction Reporting, Pharmacovigilance and Its Implementation in Cancer Hospital in Nepal: An Event Report
by: Shrestha S, et al.
Published: (2020-01-01)

Knowledge, attitude, practices, and barriers regarding pharmacovigilance and adverse drug reaction reporting among medical and dental faculties of the teaching hospitals in Bhubaneswar City
by: Avinash Jnaneswar, et al.
Published: (2020-01-01)

Examining the safety of mirabegron: an analysis of real-world pharmacovigilance data from the US FDA adverse event reporting system (FAERS) database
by: Junwei Wang, et al.
Published: (2024-03-01)

Reports of Symptoms Associated with Supraventricular Arrhythmias as a Serious Adverse Drug Reaction in the Spanish Pharmacovigilance Database
by: Javier Pueyo-Val, et al.
Published: (2023-08-01)

Age-Associated Risk of Liver-Related Adverse Drug Reactions
by: Yan-zhong Han, et al.
Published: (2022-03-01)

Pharmacovigilance: Scope for a dermatologist
by: Bhanu Prakash, et al.
Published: (2011-01-01)

Potentially Inappropriate Medication Prescribing in Older Adults According to EU(7)-Potentially Inappropriate Medication List: A Nationwide Study in Portugal
by: Daniela A. Rodrigues, MSc, et al.
Published: (2022-01-01)

Analysis of pharmacovigilance databases for spontaneous reports of adverse drug reactions related to substandard and falsified medical products: A descriptive study
by: Kevin Pozsgai, et al.
Published: (2022-09-01)

Major adverse cardiovascular events associated with testosterone treatment: a pharmacovigilance study of the FAERS database
by: Hui Zhao, et al.
Published: (2023-07-01)

Adverse reaction signals mining and hemorrhagic signals comparison of ticagrelor and clopidogrel: A pharmacovigilance study based on FAERS
by: Shu Tang, et al.
Published: (2022-10-01)

ROLE OF COMMUNITY PHARMACIST IN PHARMACOVIGILENCE
by: Nayab Farooq, et al.
Published: (2019-09-01)